Movement Disorders Clinical Practice : Impact Factor & More
eISSN: 2330-1619pISSN: 2330-1619
Share this on:
Key Metrics
CiteScore 
3.3
Impact Factor
< 5
SJR
Q3Neurology
SNIP
0.98
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Movement Disorders Clinical Practice
Movement Disorders Clinical Practice Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Movement Disorders Clinical Practice ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Movement Disorders Clinical Practice
Expanded ATXN10 Alleles in Neurodegenerative Disorders: A Case Series and Review of the Literature.
- 8 Aug 2026
- Movement disorders clinical practice
The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease.
- 8 Aug 2026
- Movement disorders clinical practice
Nutritional Factors and Weight Loss Predict Tracheostomy-Free Survival in Multiple System Atrophy.
- 7 Aug 2026
- Movement disorders clinical practice
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease
- 6 Aug 2026
- Movement Disorders Clinical Practice
Longitudinal Associations between Depression, Daytime Sleepiness, and Caregiver Strain in Parkinson's Disease
- 4 Aug 2026
- Movement Disorders Clinical Practice
Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report.
- 3 Aug 2026
- Movement disorders clinical practice
Expanded ATXN10 Alleles in Neurodegenerative Disorders: A Case Series and Review of the Literature.
- 8 Aug 2026
- Movement disorders clinical practice
The Incidence of Sensorineural Hearing Loss Diagnoses in People with and without Parkinson's Disease.
- 8 Aug 2026
- Movement disorders clinical practice
Nutritional Factors and Weight Loss Predict Tracheostomy-Free Survival in Multiple System Atrophy.
- 7 Aug 2026
- Movement disorders clinical practice
Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease
- 6 Aug 2026
- Movement Disorders Clinical Practice
Longitudinal Associations between Depression, Daytime Sleepiness, and Caregiver Strain in Parkinson's Disease
- 4 Aug 2026
- Movement Disorders Clinical Practice
Plasma 3-O-Methyldopa Concentration Monitoring for Treatment Optimization in Foslevodopa/Foscarbidopa Infusion: Implications for Corrected Levodopa Availability: A Case Report.
- 3 Aug 2026
- Movement disorders clinical practice
FAQs on Movement Disorders Clinical Practice
How long has Movement Disorders Clinical Practice been actively publishing? 
What is the publishing frequency of Movement Disorders Clinical Practice?
How many articles did Movement Disorders Clinical Practice publish last year?
What is the eISSN & pISSN for Movement Disorders Clinical Practice?
What is Citescore for Movement Disorders Clinical Practice?
What is SNIP score for Movement Disorders Clinical Practice?
What is the SJR for Movement Disorders Clinical Practice?
Who is the publisher of Movement Disorders Clinical Practice?
